(2) the advantages and disadvantages of the use of nonopioid alternatives.
(Source: P.A. 104-369, eff. 1-1-26.)
(Text of Section from P.A. 104-394)
Sec. 2310-735. Public educational effort on amniotic fluid embolism.
(a) As used in this Section, "amniotic fluid embolism" means a rare obstetric emergency in which amniotic fluid, fetal cells, hair, or other debris enters the maternal bloodstream leading to cardiovascular collapse, respiratory failure, and disseminated intravascular coagulation.
(b) The Department shall conduct educational activities for providers on the signs, symptoms, and management of amniotic fluid embolism.
(c) The Department shall make available information about amniotic fluid embolism on the Department's website.
(Source: P.A. 104-394, eff. 8-15-25.)
|